生物标志物 生物标志物
1Huashan Hospital, Fudan University, Shanghai, Shanghai, China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
阿尔茨海默病患者在一年内显示出病理和突触损失的增加. 病理和神经炎症标志物如GFAP预测突触损失和认知衰退.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物标志物研究 生物标志物研究
背景情况:
- 阿尔茨海默病 (AD) 的特点是渐进的突触损失和认知能力下降.
- 在阿尔茨海默病的进展中,病理,神经炎症和突触功能障碍之间的相互作用仍然不完全理解.
研究的目的:
- 研究突触密度变化,认知衰退以及阿尔茨海默病中病理和神经炎症标志物之间的纵向关联.
- 探索基线病理和血生物标志物对突触损失和认知衰退的预测价值.
主要方法:
- 涉及认知障碍 (CI) 个体和健康对照 (HC) 的长度研究.
- 使用正子发射断层扫描 (PET) 进行粉样蛋白,蛋白和突触密度成像 (Florbetapir,MK6240,SynVesT-1).
- 在一年的随访期间评估了血生物标志物 (p-tau 181,NfL,GFAP) 和认知功能 (MMSE). 采用统计分析,包括t测试,相关性,一般线性模型和调解分析.
主要成果:
- 与健康对照人群相比,认知障碍的个体在中间叶中表现出更大的纵向突触损失,以及新皮质负荷增加.
- 基线tau病理 (tau负担,血p-tau 181) 和血GFAP与突触密度负相关,并预测了纵向突触损失.
- 血GFAP调解了tau病理和突触密度之间的关系. 纵向突触密度变化与MMSE得分变化正相关. 血p-tau 181和GFAP预测认知能力下降,而tau病理介导了血GFAP对认知的影响.
结论:
- 认知障碍的个体在一年内经历了加速的突触损失和积累.
- 基线病理和血GFAP是阿尔茨海默病中突触损失和认知衰退的显著预测因素.
- 研究结果表明,病理和神经炎症之间存在协同作用,导致AD的突触损失和认知障碍.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516